U.S. Celanese Corporation, Disc Medicine, Editas Medicine
Nov 5 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Celanese Corporation, Disc Medicine and Editas Medicine, on Tuesday.
HIGHLIGHTS
* Affiliated Managers Group Inc AMG.N: TD Cowen cuts to hold from buy |
* Celanese Corporation CE.N: Wells Fargo cuts to equal weight from overweight |
* Disc Medicine Inc IRON.O: Raymond James raises to strong buy from outperform |
* Editas Medicine Inc EDIT.O: Raymond James cuts to market perform from outperform |
* Neumora Therapeutics Inc NMRA.O: JP Morgan cuts to neutral from overweight |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* 8X8 Inc EGHT.O: Barclays raises target price to $2.50 from $2 |
* 8X8 Inc EGHT.O: Wells Fargo raises target price to $2 from $1.50 |
* Abbott ABT.N: Barclays raises target price to $149 from $143 |
* Adverum Biotechnologies Inc ADVM.O: RBC cuts target price to $10 from $12 |
* Affiliated Managers Group AMG.N: Deutsche Bank cuts target price to $204 from $219 |
* Affiliated Managers Group AMG.N: Barrington Research cuts target to $200 from $210 |
* Affiliated Managers Group AMG.N: Jefferies cuts target price to $207 from $211 |
* Affiliated Managers Group AMG.N: TD Cowen cuts target price to $177 from $226 |
* Affiliated Managers Group AMG.N: TD Cowen cuts to hold from buy |
* Aflac Incorporated AFL.N: Wells Fargo raises target price to $107 from $106 |
* AIG AIG.N: BofA Global Research cuts price objective to $82 from $86 |
* Air Transport Services Group Inc ATSG.O: Truist Securities raises PT to $22.50 from $15 |
* Altice USA Inc ATUS.N: TD Cowen cuts target price to $3.50 from $6 |
* Api Group Corp APG.N: Barclays raises target price to $44 from $43 |
* Ares Management Corp ARES.N: JP Morgan cuts target price to $174 from $176 |
* Arhaus Inc ARHS.O: Telsey Advisory Group cuts target price to $12 from $15 |
* Armstrong World Industries Inc AWI.N: Jefferies raises target price to $143 from $122 |
* Asbury Automotive Group Inc ABG.N: JP Morgan cuts target price to $260 from $265 |
* Astera Labs ALAB.O: Craig-Hallum raises target price to $105 from $75 |
* Astera Labs ALAB.O: Deutsche Bank raises target price to $100 from $60 |
* Astera Labs ALAB.O: Barclays raises target price to $87 from $70 |
* Astera Labs ALAB.O: JP Morgan raises target price to $110 from $70 |
* Astera Labs ALAB.O: Morgan Stanley raises target price to $94 from $74 |
* Astera Labs ALAB.O: Needham raises target price to $100 from $80 |
* Astera Labs ALAB.O: Stifel raises target price to $100 from $80 |
* Autonation AN.N: JP Morgan cuts target price to $180 from $190 |
* Avis Budget Group CAR.O: Deutsche Bank cuts target price to $143 from $145 |
* Baldwin Insurance Group Inc BWIN.O: Jefferies cuts target price to $43 from $46 |
* Baldwin Insurance Group Inc BWIN.O: JP Morgan cuts target price to $47 from $54 |
* Biocryst Pharmaceuticals Inc BCRX.O: Barclays raises target price to $8 from $7 |
* Biomarin Pharmaceutical Inc BMRN.O: Wedbush assumes coverage with outperform rating |
* Biomarin Pharmaceutical Inc BMRN.O: Wedbush assumes coverage with target price $94 |
* Booking Holdings Inc BKNG.O: Mizuho raises target price to $5,400 from $4,800 |
* Booz Allen Hamilton Holding Corp BAH.N: JP Morgan raises target price to $170 from $158 |
* Bowlero Corp BOWL.N: JP Morgan cuts target price to $15 from $16 |
* Bright Horizons Family Solutions Inc BFAM.N: JP Morgan raises target to $149 from $137 |
* Bright Horizons Family Solutions Inc BFAM.N: Morgan Stanley raises PT to $108 from $100 |
* Bright Horizons Family Solutions Inc BFAM.N: UBS raises PT to $148 from $145 |
* Brookfield Asset Management Ltd BAM.N: JP Morgan raises target price to $52 from $51 |
* BWX Technologies Inc BWXT.N: Truist Securities raises target price to $106 from $95 |
* Bxp Inc BXP.N: UBS raises target price to $80 from $64 |
* Cabot Corp CBT.N: Mizuho raises target price to $122 from $103 |
* Camp4 Therapeutics Corp CAMP.O: JP Morgan initiates coverage with overweight rating |
* Camp4 Therapeutics Corp CAMP.O: JP Morgan initiates coverage with price target $23 |
* Camp4 Therapeutics Corp CAMP.O: Leerink Partners initiates coverage with outperform rating |
* Camp4 Therapeutics Corp CAMP.O: Leerink Partners initiates coverage with target price $17 |
* Caredx Inc CDNA.O: BTIG cuts target price to $35 from $40 |
* Castle Biosciences Inc CSTL.O: Guggenheim raises target price to $37 from $32 |
* Castle Biosciences Inc CSTL.O: Leerink Partners raises target price to $50 from $45 |
* Castle Biosciences Inc CSTL.O: Scotiabank raises target price to $44 from $37 |
* Celanese Corp CE.N: Mizuho cuts target price to $120 from $132 |
* Celanese Corp CE.N: Wells Fargo cuts to equal weight from overweight |
* Centene Corp CNC.N: Mizuho cuts target price to $71 from $77 |
* Centerpoint Energy CNP.N: RBC raises target price to $31 from $30 |
* Century Aluminum Co CENX.O: BMO raises target price to $18 from $16 |
* Century Casinos Inc CNTY.O: Stifel raises target price to $5 from $4 |
* Ceribell Inc CBLL.O: BofA Global Research initiates coverage with buy rating |
* Ceribell Inc CBLL.O: BofA Global Research initiates coverage with price objective $32 |
* Ceribell Inc CBLL.O: Canaccord Genuity initiates coverage with buy rating; PT $30 |
* Ceribell Inc CBLL.O: JP Morgan initiates coverage with overweight rating; PT $32 |
* Chemed Corp CHE.N: RBC cuts target price to $633 from $697 |
* Chemours CC.N: Barclays raises target price to $23 from $21 |
* Chemours CC.N: Morgan Stanley cuts target price to $25 from $30 |
* Cheniere Energy Inc LNG.N: TD Cowen raises target price to $202 from $192 |
* Choice Hotels International Inc CHH.N: Barclays raises target price to $123 from $112 |
* Choice Hotels International Inc CHH.N: HSBC raises target price to $142 from $123 |
* Church & Dwight Co Inc CHD.N: Barclays cuts target price to $85 from $86 |
* Cigna CI.N: Barclays raises target price to $420 from $405 |
* Cigna CI.N: Piper Sandler raises target price to $394 from $392 |
* Cirrus Logic Inc CRUS.O: Barclays cuts target price to $105 from $120 |
* Cirrus Logic Inc CRUS.O: Stifel cuts target price to $140 from $165 |
* Cirrus Logic Inc CRUS.O: Susquehanna cuts target price to $135 from $160 |
* Clearway Energy Inc CWENa.N: RBC raises target price to $31 from $30 |
* CMS Energy Corp CMS.N: Jefferies initiates coverage with buy rating |
* CMS Energy Corp CMS.N: Jefferies initiates coverage with price target $76 |
* Cognex Corp CGNX.O: Truist Securities cuts target price to $43 from $46 |
* Cognex Corp CGNX.O: Truist Securities cuts to hold from buy |
* Constellation Energy Corp CEG.O: Mizuho cuts target price to $235 from $264 |
* Corebridge Financial Inc CRBG.N: Barclays raises target price to $36 from $34 |
* Corebridge Financial Inc CRBG.N: Morgan Stanley raises target price to $34 from $31 |
* Crescent Energy Co CRGY.N: Mizuho raises target price to $14 from $13 |
* Curtiss-Wright Corp CW.N: Morgan Stanley raises target price to $395 from $334 |
* Digitalbridge Group Inc DBRG.N: Raymond James cuts target price to $16 from $19 |
* Disc Medicine Inc IRON.O: BMO raises target price to $112 from $70 |
* Disc Medicine Inc IRON.O: Leerink Partners raises target price to $85 from $65 |
* Disc Medicine Inc IRON.O: Raymond James raises target price to $110 from $66 |
* Disc Medicine Inc IRON.O: Raymond James raises to strong buy from outperform |
* Disc Medicine Inc IRON.O: Scotiabank raises target price to $70 from $62 |
* Dollar General Corp DG.N: JP Morgan cuts target price to $82 from $97 |
* Dollar Tree Inc DLTR.O: JP Morgan raises target price to $82 from $70 |
* Dollar Tree Inc DLTR.O: Telsey Advisory Group cuts target price to $75 from $95 |
* Dollar Tree Inc DLTR.O: Telsey Advisory Group cuts to market perform from outperform |
* E W Scripps Co SSP.O: Benchmark cuts target price to $7 from $11 |
* eBay EBAY.O: Bernstein raises to outperform from market perform |
* eBay EBAY.O: Mizuho raises target price to $60 from $55 |
* eBay EBAY.O: Truist Securities raises target price to $62 from $58 |
* Editas Medicine Inc EDIT.O: Barclays cuts target price to $5 from $7 |
* Editas Medicine Inc EDIT.O: Raymond James cuts to market perform from outperform |
* Editas Medicine Inc EDIT.O: RBC cuts target price to $5 from $8 |
* Editas Medicine Inc EDIT.O: Truist Securities cuts target price to $8 from $12 |
* Elevance Health ELV.N: Mizuho cuts target price to $505 from $585 |
* Entegris Inc ENTG.O: BMO cuts target price to $135 from $145 |
* Entegris Inc ENTG.O: Craig-Hallum cuts target price to $130 from $150 |
* Entegris Inc ENTG.O: Deutsche Bank cuts target price to $115 from $145 |
* Entegris Inc ENTG.O: Mizuho cuts target price to $125 from $143 |
* Entegris Inc ENTG.O: Needham cuts target price to $120 from $135 |
* Entegris Inc ENTG.O: UBS cuts target price to $115 from $130 |
* Entergy ETR.N: Barclays raises target price to $152 from $137 |
* Entergy ETR.N: RBC raises target price to $150 from $140 |
* EQT Corp EQT.N: Mizuho raises target price to $45 from $41 |
* Essential Utilities, Inc. WTRG.N: Wells Fargo cuts target price to $43 from $45 |
* Everquote Inc EVER.O: JP Morgan cuts target price to $28 from $34 |
* Everquote Inc EVER.O: Needham cuts target price to $30 from $38 |
* Exelon Corp EXC.O: RBC raises target price to $42 from $40 |
* Exxon Mobil XOM.N: Gerdes Energy Research cuts target price by $2 to $131 |
* Exxon Mobil XOM.N: HSBC raises target price to $125 from $120 |
* Fidelity National Information Services FIS.N: Morgan Stanley ups PT to $87 from $80 |
* Fidelity National Information Services FIS.N: UBS raises PT to $94 from $80 |
* FirstEnergy FE.N: RBC cuts target price to $48 from $49 |
* Fis FIS.N: JP Morgan raises target price to $99 from $89 |
* Fis FIS.N: KBW raises target price to $102 from $97 |
* Fis FIS.N: Mizuho raises target price to $104 from $91 |
* Fis FIS.N: Raymond James raises target price to $115 from $89 |
* Fis FIS.N: RBC raises target price to $104 from $95 |
* Fis FIS.N: Susquehanna raises target price to $103 from $88 |
* Fis FIS.N: TD Cowen raises target price to $86 from $78 |
* Forward Air Corp FWRD.O: Jefferies cuts target price to $45 from $47 |
* Fox Corp FOXA.O: Deutsche Bank raises target price to $47 from $42 |
* Fox Corp FOXA.O: Guggenheim raises target price to $50 from $45 |
* Fox Corp FOXA.O: JP Morgan raises target price to $42 from $41 |
* Fox Corp FOXA.O: Macquarie raises target price to $39 from $35 |
* Fox Corp FOXA.O: Moffettnathanson raises target price by $2 to $51 |
* Fox Corp FOXA.O: TD Cowen raises target price to $42 from $36 |
* Fox Corp FOXA.O: UBS raises target price to $50 from $44 |
* Fox Corp FOXA.O: Morgan Stanley raises target price to $42 from $40 |
* Fox Corp FOXA.O: Wells Fargo raises target price to $49 from $46 |
* Franklin Resources BEN.N: Deutsche Bank cuts target price to $19 from $20 |
* Franklin Resources BEN.N: Jefferies cuts target price to $20 from $21 |
* Franklin Resources BEN.N: KBW cuts target price to $19 from $20 |
* Franklin Resources BEN.N: TD Cowen cuts target price to $18.50 from $20 |
* Franklin Resources BEN.N: Wells Fargo raises target price to $19.50 from $19 |
* Freshpet Inc FRPT.O: Deutsche Bank raises target price to $163 from $161 |
* Freshpet Inc FRPT.O: Benchmark raises target price to $185 |
* Freshpet Inc FRPT.O: D.A. Davidson raises target price to $189 from $183 |
* Freshpet Inc FRPT.O: Jefferies raises target price to $162 from $123 |
* Freshpet Inc FRPT.O: JP Morgan raises target price to $154 from $126 |
* Freshpet Inc FRPT.O: Piper Sandler raises target price to $180 from $150 |
* Freshpet Inc FRPT.O: TD Cowen raises target price to $174 from $160 |
* Freshpet Inc FRPT.O: Truist Securities raises target price to $170 from $160 |
* Freshpet Inc FRPT.O: Wells Fargo raises target price to $175 from $157 |
* Frontdoor Inc FTDR.O: Truist Securities raises target price to $58 from $56 |
* Gates Industrial Corporation Plc GTES.N: Barclays raises target price to $21 from $16 |
* Geron Corporation GERN.O: H.C. Wainwright initiates coverage with buy rating |
* Glaukos Corp GKOS.N: JP Morgan raises target price to $145 from $130 |
* Glaukos Corp GKOS.N: Wells Fargo raises target price to $145 from $135 |
* Group 1 Automotive Inc GPI.N: JP Morgan raises target price to $425 from $420 |
* Hackett Group Inc HCKT.O: Craig-Hallum raises target price to $32 from $30 |
* Heidrick & Struggles International Inc HSII.O: Truist Securities ups PT to $40 from $33 |
* Hims & Hers Health Inc HIMS.N: Canaccord Genuity raises target price to $28 from $24 |
* Hims & Hers Health Inc HIMS.N: Leerink Partners cuts target price to $24 from $26 |
* Hims & Hers Health Inc HIMS.N: Needham raises target price to $28 from $24 |
* Hims & Hers Health Inc HIMS.N: Piper Sandler raises target price to $21 from $18 |
* Hologic Inc HOLX.O: JP Morgan raises target price to $94 from $92 |
* Hologic Inc HOLX.O: Mizuho cuts target price to $87 from $90 |
* Hologic Inc HOLX.O: Raymond James raises target price to $95 from $93 |
* Hologic Inc HOLX.O: RBC raises target price to $89 from $86 |
* Hologic Inc HOLX.O: UBS raises target price to $90 from $84 |
* Home Depot Inc HD.N: Barclays raises target price to $420 from $372 |
* Homestreet Inc HMST.O: Wedbush raises to outperform from neutral |
* Hubspot Inc HUBS.N: Citigroup raises target price to $708 from $629 |
* Hudson Technologies Inc HDSN.O: Craig-Hallum cuts target price to $7 from $10 |
* Hudson Technologies Inc HDSN.O: Craig-Hallum cuts to hold from buy |
* Humacyte Inc HUMA.O: H.C. Wainwright raises target price to $12 from $6 |
* Huntsman Corp HUN.N: UBS cuts target price to $23 from $24 |
* Idacorp Inc IDA.N: BofA Global Research raises price objective to $117 from $113 |
* Idacorp Inc IDA.N: BofA Global Research raises to buy from neutral |
* Ideaya Biosciences Inc IDYA.O: Leerink Partners cuts target price to $27 from $41 |
* Ideaya Biosciences Inc IDYA.O: Leerink Partners cuts to market perform from outperform |
* Illumina Inc ILMN.O: Barclays raises target price to $145 from $135 |
* Illumina Inc ILMN.O: Canaccord Genuity raises target price to $145 from $130 |
* Illumina Inc ILMN.O: Citigroup raises target price to $190 from $155 |
* Illumina Inc ILMN.O: Guggenheim raises target price to $170 from $150 |
* Illumina Inc ILMN.O: JP Morgan raises target price to $140 from $125 |
* Illumina Inc ILMN.O: Leerink Partners cuts target price to $175 from $200 |
* Illumina Inc ILMN.O: RBC raises target price to $254 from $252 |
* Illumina Inc ILMN.O: UBS raises target price to $145 from $133 |
* Indie Semiconductor Inc INDI.O: Benchmark cuts target price to $9 from $12 |
* Inozyme pharma Inc INZY.O: Wedbush cuts target price to $12 from $15 |
* Inspire Medical Systems Inc INSP.N: Morgan Stanley raises target price to $230 from $210 |
* Inspire Medical Systems Inc INSP.N: Piper Sandler raises target price to $260 from $255 |
* Inspire Medical Systems Inc INSP.N: Truist Securities raises target to $250 from $240 |
* Inspire Medical Systems Inc INSP.N: Wells Fargo raises target price to $198 from $187 |
* Intapp Inc INTA.O: Barclays raises target price to $48 from $44 |
* Intapp Inc INTA.O: Piper Sandler raises target price to $60 from $46 |
* Intapp Inc INTA.O: Raymond James raises target price to $55 from $46 |
* Intapp Inc INTA.O: Truist Securities raises target price to $55 from $47 |
* Integra Lifesciences Holdings Corp IART.O: Citigroup raises target to $22 from $16 |
* Intrepid Potash Inc IPI.N: UBS raises target price to $19 from $18 |
* Keros Therapeutics Inc KROS.O: Wedbush assumes coverage with outperform rating; PT $84 |
* Kosmos Energy Ltd KOS.N: Benchmark cuts target price to $7 from $8 |
* Kosmos Energy Ltd KOS.N: Bernstein cuts target price to $4 from $5 |
* Krispy Kreme Inc DNUT.O: Morgan Stanley resumes coverage with equal-weight rating |
* Krispy Kreme Inc DNUT.O: Morgan Stanley resumes coverage with price target $14 |
* Krystal Biotech Inc KRYS.O: Guggenheim cuts target price to $195 from $200 |
* Landsea Homes Corp LSEA.O: Wedbush cuts target price to $16 from $17 |
* Lattice Semiconductor Corp LSCC.O: Deutsche Bank cuts target price to $50 from $56 |
* Lattice Semiconductor Corp LSCC.O: Needham cuts target price to $56 from $61 |
* Lattice Semiconductor Corp LSCC.O: Raymond James cuts target price to $52 from $55 |
* Lattice Semiconductor Corp LSCC.O: Susquehanna cuts target price to $55 from $65 |
* Lattice Semiconductor Corp LSCC.O: TD Cowen cuts target price to $50 from $60 |
* Lemonade Inc LMND.N: Jefferies raises target price to $17 from $14 |
* Lithia Motors Inc LAD.N: JP Morgan raises target price to $405 from $375 |
* Live Nation Entertainment LYV.N: Deutsche Bank raises target price to $130 from $122 |
* Madrigal Pharmaceuticals Inc MDGL.O: B. Riley raises target price to $236 from $194 |
* Marqeta Inc MQ.O: Deutsche Bank cuts target price to $4 from $9 |
* Marqeta Inc MQ.O: Deutsche Bank cuts to hold from buy |
* Marqeta Inc MQ.O: JP Morgan cuts target price to $5 from $6 |
* Marqeta Inc MQ.O: KBW cuts target price to $5 from $6 |
* Marqeta Inc MQ.O: KeyBanc cuts to sector weight from overweight |
* Marqeta Inc MQ.O: Mizuho cuts target price to $5 from $7 |
* Marqeta Inc MQ.O: Monness Crespi Hardt cuts to neutral from buy |
* Marqeta Inc MQ.O: Morgan Stanley cuts target price to $5 from $7 |
* Marqeta Inc MQ.O: Susquehanna cuts target price to $7 from $9 |
* Marqeta Inc MQ.O: Wells Fargo cuts target price to $5 from $7 |
* Marqeta Inc MQ.O: Wells Fargo cuts to equal weight from overweight |
* Marriott MAR.O: Barclays raises target price to $249 from $240 |
* Marriott MAR.O: Bernstein raises target price to $290 from $262 |
* Marriott MAR.O: BMO raises target price to $265 from $255 |
* Marriott MAR.O: Jefferies raises target price to $251 from $225 |
* Marriott MAR.O: JP Morgan raises target price to $251 from $237 |
* Marriott MAR.O: Mizuho raises target price to $246 from $233 |
* Marriott MAR.O: Deutsche Bank raises target price to $220 from $216 |
* Mastec Inc MTZ.N: Truist Securities raises target price to $173 from $133 |
* Mastec Inc MTZ.N: Truist Securities raises to buy from hold |
* MDU Resources Group Inc MDU.N: BofA Global Research cuts price objective to $17 from $31 |
* MDU Resources Group Inc MDU.N: BofA Global Research raises to buy from neutral |
* Meritage Homes Corp MTH.N: KBW cuts target price to $198 from $210 |
* Metlife Inc MET.N: Wells Fargo raises target price to $93 from $92 |
* Monster Beverage Corporation MNST.O: Wells Fargo raises target price to $60 from $57 |
* Napco Security Technologies Inc NSSC.O: Needham cuts target price to $52 from $57 |
* Napco Security Technologies Inc NSSC.O: TD Cowen cuts target price to $46 from $60 |
* Navitas Semiconductor Corp NVTS.O: Deutsche Bank cuts target price to $4 from $6 |
* Navitas Semiconductor Corp NVTS.O: Craig-Hallum cuts target price to $4.25 from $6.50 |
* Navitas Semiconductor Corp NVTS.O: Jefferies cuts target price to $3 from $4 |
* Navitas Semiconductor Corp NVTS.O: Morgan Stanley cuts target price to $2.20 from $2.60 |
* Navitas Semiconductor Corp NVTS.O: Needham cuts target price to $4 from $5 |
* Neumora Therapeutics Inc NMRA.O: JP Morgan cuts target price to $15 from $18 |
* Neumora Therapeutics Inc NMRA.O: JP Morgan cuts to neutral from overweight |
* New York Times Co NYT.N: Guggenheim raises target price to $55 from $53 |
* New York Times Co NYT.N: JP Morgan raises target price to $62 from $58 |
* Newmont NEM.N: Bernstein raises target price to $58 from $55 |
* Nextera Energy Partners LP NEP.N: Jefferies cuts target price to $25 from $27 |
* Owens & Minor Inc OMI.N: Barclays cuts target price to $14 from $18 |
* Owens & Minor Inc OMI.N: Baird cuts target price to $14 from $19 |
* Owens & Minor Inc OMI.N: Citigroup cuts target price to $18.50 from $21 |
* Owens & Minor Inc OMI.N: UBS cuts target price to $25 from $28 |
* Palantir Technologies Inc PLTR.N: D.A. Davidson raises target price to $47 from $28 |
* Palantir Technologies Inc PLTR.N: Mizuho raises target price to $37 from $30 |
* Palantir Technologies Inc PLTR.N: Northland Capital raises target price to $38 from $35 |
* Palantir Technologies Inc PLTR.N: RBC raises target price to $11 from $9 |
* Palantir Technologies Inc PLTR.N: Wedbush raises target price to $57 from $45 |
* Pediatrix Medical Group Inc MD.N: UBS raises target price to $16.50 from $10.50 |
* Peloton Interactive PTON.O: Deutsche Bank raises target price to $6.20 from $3.90 |
* PRA Group Inc PRAA.O: Truist Securities raises target price to $31 from $28 |
* Protagonist Therapeutics Inc PTGX.O: Wedbush initiates coverage with outperform rating |
* Protagonist Therapeutics Inc PTGX.O: Wedbush initiates coverage with target price $58 |
* Prudential Financial Inc PRU.N: Wells Fargo raises target price to $117 from $116 |
* Public Service Enterprise Group Inc PEG.N: Barclays cuts target price to $88 from $98 |
* Public Service Enterprise Group Inc PEG.N: BMO cuts target price to $87 from $90 |
* Public Service Enterprise Group Inc PEG.N: Guggenheim cuts target price to $94 from $97 |
* Purple Innovation Inc PRPL.O: Wedbush cuts target price to $0.90 from $1.10 |
* Qualcomm QCOM.O: JP Morgan cuts target price to $195 from $210 |
* Quinstreet Inc QNST.O: Barrington Research raises target price by $7 to $29 |
* Quinstreet Inc QNST.O: Craig-Hallum raises target price to $32 from $25 |
* Quinstreet Inc QNST.O: Stephens raises target price to $27 from $23 |
* Ralph Lauren Corp RL.N: TD Cowen raises target price to $251 from $208 |
* RBC Bearings Inc RBC.N: Morgan Stanley raises target price to $332 from $330 |
* Realreal Inc REAL.O: UBS raises target price to $3.25 from $3 |
* Retail Opportunity Investments ROIC.O: KeyBanc cuts to sector weight from overweight |
* Revvity Inc RVTY.N: Bernstein cuts target price to $145 from $150 |
* Revvity Inc RVTY.N: Raymond James raises target price to $146 from $144 |
* Rezolute Inc RZLT.O: Wedbush initiates coverage with outperform rating; PT $12 |
* Roblox Corp RBLX.N: Citigroup raises target price to $63 from $53 |
* Root Inc ROOT.O: KBW raises target price to $90 from $82 |
* Safehold Inc SAFE.N: Wedbush cuts target price to $23 from $25 |
* Sana Biotechnology Inc SANA.O: H.C. Wainwright cuts target price to $8 from $11 |
* Sangamo Therapeutics Inc SGMO.O: H.C. Wainwright raises target price to $10 from $5 |
* Sanmina Corp SANM.O: Craig-Hallum raises target price to $69 from $62 |
* Sensata Technologies Holding Plc ST.N: JP Morgan cuts target price to $32 from $34 |
* Sensata Technologies Holding Plc ST.N: Oppenheimer cuts target price to $44 from $47 |
* Sensata Technologies Holding Plc ST.N: Truist Securities cuts target to $33 from $38 |
* SES Ai SES.N: Deutsche Bank cuts target price to $1 from $1.50 |
* Shake Shack Inc SHAK.N: Stifel raises target price to $115 from $100 |
* Silicon Labs SLAB.O: Morgan Stanley cuts target price to $97 from $123 |
* Silicon Labs SLAB.O: Barclays cuts target price to $75 from $120 |
* Silicon Labs SLAB.O: JP Morgan cuts target price to $135 from $150 |
* Silicon Labs SLAB.O: Needham cuts target price to $120 from $150 |
* Silicon Labs SLAB.O: Stifel cuts target price to $135 from $160 |
* Skyward Specialty Insurance Group Inc SKWD.O: Raymond James raises PT to $55 from $45 |
* Skywest Inc SKYW.O: TD Cowen raises target price to $120 from $95 |
* SM Energy Co SM.N: Susquehanna cuts target price to $46 from $48 |
* Stanley Black & Decker SWK.N: JP Morgan raises target price to $100 from $88 |
* Summit Materials Inc SUM.N: D.A. Davidson raises target price to $47 from $41 |
* Tactile Systems Technology Inc TCMD.O: BTIG cuts to neutral from buy |
* Targa Resources Corp TRGP.N: Truist Securities raises target price to $175 from $150 |
* Tempus Ai Inc TEM.O: Needham raises target price to $56 from $47 |
* Teradata Corp TDC.N: Morgan Stanley raises target price to $31 from $30 |
* Teradata Corp TDC.N: Barclays cuts target price to $29 from $30 |
* Teradata Corp TDC.N: Northland Capital cuts target price to $37 from $38 |
* Teradata Corp TDC.N: UBS raises target price to $26 from $24 |
* The Hackett Group Inc HCKT.O: Craig-Hallum raises target price to $32 from $30 |
* TPG Inc TPG.O: BMO raises target price to $60 from $45 |
* TPG Inc TPG.O: Deutsche Bank raises target price to $67 from $65 |
* TPG Inc TPG.O: Wells Fargo raises target price to $68 from $67 |
* Tuhura Biosciences Inc HURA.O: Maxim Group initiates coverage with buy rating; PT $15 |
* UDR Inc UDR.N: RBC cuts target price to $45 from $46 |
* Upstream Bio Inc UPB.O: JP Morgan initiates coverage with overweight rating; PT $38 |
* Upstream Bio Inc UPB.O: TD Cowen initiates coverage with buy rating |
* V2X Inc VVX.N: Raymond James raises target price to $72 from $60 |
* Verrica Pharmaceuticals Inc VRCA.O: RBC cuts target price to $2 from $10 |
* Verrica Pharmaceuticals Inc VRCA.O: RBC cuts to sector perform from outperform |
* Vertex Pharmaceuticals Inc VRTX.O: Morgan Stanley raises target price to $476 from $473 |
* Vertex Pharmaceuticals Inc VRTX.O: Bernstein raises target price to $506 from $502 |
* Vertex Pharmaceuticals Inc VRTX.O: Canaccord Genuity raises PT to $408 from $361 |
* Vertex Pharmaceuticals Inc VRTX.O: JP Morgan cuts target price to $503 from $510 |
* Vertex Pharmaceuticals Inc VRTX.O: RBC raises target price to $451 from $437 |
* Vertex Pharmaceuticals Inc VRTX.O: Scotiabank raises target price to $486 from $480 |
* Vertex Pharmaceuticals Inc VRTX.O: UBS raises target price to $586 from $562 |
* Vimeo Inc VMEO.O: Piper Sandler raises target price to $7 from $5 |
* Vimeo Inc VMEO.O: Truist Securities raises target price to $9 from $7 |
* Viper Energy Inc VNOM.O: Barclays raises target price to $58 from $52 |
* Vontier Corp VNT.N: Barclays raises target price to $46 from $44 |
* Voya Financial Inc VOYA.N: Morgan Stanley cuts target price to $81 from $82 |
* Wesco International Inc WCC.N: Stephens raises target price to $205 from $190 |
* Williams Companies Inc WMB.N: Truist Securities raises target price to $52 from $42 |
* Wynn Resorts Ltd WYNN.O: Barclays cuts target price to $119 from $125 |
* Wynn Resorts Ltd WYNN.O: Deutsche Bank cuts target price to $118 from $122 |
* Wynn Resorts Ltd WYNN.O: JP Morgan raises target price to $113 from $101 |
* Wynn Resorts Ltd WYNN.O: Wells Fargo cuts target price to $122 from $125 |
* Xcel Energy XEL.O: RBC raises target price to $68 from $66 |
* Xometry Inc XMTR.O: Craig-Hallum raises target price to $30 from $20 |
(Compiled by Bengaluru Newsroom)
</body></html>Související aktiva
Poslední novinky
Zřeknutí se odpovědnosti: Subjekty skupiny XM Group poskytují služby a přístup do naší online obchodní platformy v režimu „execution-only”, což osobám umožní prohlížet a/nebo použít obsah, dostupný zde nebo prostřednictvím webové stránky, který není určený ke změně nebo šíření. Na takový přístup a použití se vždy vztahují: (i) Všeobecné obchodní podmínky; (ii) Upozornění na rizika; a (iii) Úplné zřeknutí se odpovědnosti. Takový obsah je proto poskytovaný pouze jako obecné informace. Mějte především na paměti, že obsah naší online obchodní platformy není ani žádostí, ani nabídkou vstupu do jakýchkoliv transakcí na finančních trzích. Obchodování na jakémkoliv finančním trhu zahrnuje významnou úroveň rizika pro váš kapitál.
Veškerý materiál, zveřejněný na naší online obchodní platformě, je určený pouze pro vzdělávací/informační účely a neobsahuje ani by neměl být považovaný za finanční, investiční, daňové nebo obchodní rady a doporučení, ani záznamy o našich obchodních cenách, nebo nabídku transakce s jakýmikoliv finančními instrumenty, či nevyžádadnou propagaci pro vaši osobu.
Jakýkoliv obsah třetích stran a také obsah, připravený společností XM, jako jsou názory, novinky, výzkum, analýzy, ceny, další informace nebo odkazy na webové stránky třetích stran, které jsou zobrazeny na tomto webu, jsou poskytovány v neupravené verzi jako obecný tržní komentář, a nepředstavují investiční radu. Pokud je jakýkoliv obsah uváděný jako investiční výzkum, musíte si uvědomit a přijmout, že tento obsah nebyl určený a nebyl připravený v souladu se zákonnými požadavky, vytvořenými pro podporu nezávislosti investičního výzkumu, a jako takový by měl být podle příslušných zákonů a předpisu považovaný pouze za marketingovou komunikaci. Ujistěte se, že jste si přečetli a plně rozumíte našemu Oznámení o seznámení se s riziky a investičním výzkumu, který není nezávislý, týkající se výše uvedených informací, a ke kterým lze přejít zde.
